MDPI and ACS Style
Mori, T.; Yoshida, M.; Hazekawa, M.; Ishibashi, D.; Hatanaka, Y.; Nagao, T.; Kakehashi, R.; Kojima, H.; Uno, R.; Ozeki, M.;
et al. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans. Int. J. Mol. Sci. 2021, 22, 5097.
https://doi.org/10.3390/ijms22105097
AMA Style
Mori T, Yoshida M, Hazekawa M, Ishibashi D, Hatanaka Y, Nagao T, Kakehashi R, Kojima H, Uno R, Ozeki M,
et al. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans. International Journal of Molecular Sciences. 2021; 22(10):5097.
https://doi.org/10.3390/ijms22105097
Chicago/Turabian Style
Mori, Takeshi, Miyako Yoshida, Mai Hazekawa, Daisuke Ishibashi, Yoshiro Hatanaka, Toshihiro Nagao, Rie Kakehashi, Honami Kojima, Rio Uno, Minoru Ozeki,
and et al. 2021. "Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against Staphylococcus aureus, Escherichia coli, and Candida albicans" International Journal of Molecular Sciences 22, no. 10: 5097.
https://doi.org/10.3390/ijms22105097